Ascendance Biotechnology Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Ascendance Biotechnology General Information

Description

Developer of stem cell derived products intended to offer unique cell-based assays. The company's services include application-directed, cellular micro-patterning drug and chemical screening, predictive analysis and basic research, enabling pharmaceutical companies to get basic stem cell research through clinical manufacturing using products that are translatable to the clinic.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Acquirer
IVT Holdings
Corporate Office
  • 200 Boston Avenue
  • Suite 1500
  • Medford, MA 02155
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ascendance Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 27-Mar-2018 00000 Completed Generating Revenue
2. Angel (individual) 17-May-2016 00000 00000 Completed Startup
1. Angel (individual) 21-Dec-2015 $650K $650K Completed Startup
To view Ascendance Biotechnology’s complete valuation and funding history, request access »

Ascendance Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of stem cell derived products intended to offer unique cell-based assays. The company's services include appli
Biotechnology
Medford, MA
2 As of 2016
00000
000000&0 00000

000000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volu
0000000000000
San Diego, CA
00 As of 0000
000.00
000000&0

000000

ulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
0000000000000
Vancouver, Canada
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ascendance Biotechnology Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Organovo Formerly VC-backed San Diego, CA 00 000.00 000000&0
Aspect Biosystems Venture Capital-Backed Vancouver, Canada 00 000.00 0000000000 0 000.00
Lonza Group Corporation Basel, Switzerland 00000 00000 00000000000 00000
3D Biotek Corporate Backed or Acquired Bridgewater, NJ 0 000000&0
AxoSim Venture Capital-Backed New Orleans, LA 00 00.000 0000000000 0 00.000
To view Ascendance Biotechnology’s complete competitors history, request access »

Ascendance Biotechnology Patents

Ascendance Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10696949-B2 Systems and methods for canine liver modeling Active 26-Jan-2015 0000000000 0
US-20160369238-A1 Systems and methods for canine liver modeling Active 26-Jan-2015 0000000000 0
US-20160363584-A1 Systems and methods for studying inflammation-drug interactions Pending 12-Mar-2012 00000000000 0
CA-2825274-A1 Systems and methods for micro-contact stamping Active 21-Jan-2011 000000000
AU-2012207545-B2 Systems and methods for micro-contact stamping Active 21-Jan-2011 C12M33/02 0
To view Ascendance Biotechnology’s complete patent history, request access »

Ascendance Biotechnology Executive Team (2)

Name Title Board Seat Contact Info
Jeffrey Janus Co-Founder, President & Board Member
You’re viewing 1 of 2 executive team members. Get the full list »

Ascendance Biotechnology Board Members (6)

Name Representing Role Since
Jeffrey Janus Ascendance Biotechnology Co-Founder, President & Board Member 000 0000
Morton Collins Ph.D Self Board Member 000 0000
Robert Wilkins Self Board Member 000 0000
You’re viewing 3 of 6 board members. Get the full list »

Ascendance Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ascendance Biotechnology Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AgeX Therapeutics Corporation Minority 000 0000 000000 0
To view Ascendance Biotechnology’s complete investors history, request access »

Ascendance Biotechnology Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hepregen 06-Nov-2015 000000 00 Biotechnology
To view Ascendance Biotechnology’s complete acquisitions history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »